Gene Activated Matrix (GAM) technology utilizing well characterized growth factor or cytokine genes circumvents the protein delivery and maintenance hurdles in tissue repair and regeneration indications.

GAM provides a method of targeting repair and progenitor cells. Any biocompatible matrix, natural or synthetic, may be used; the formulation selected will depend upon the local environment and the particular clinical indication.

  



Tissue Repair Company (TRC) is a San Diego biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is broadly based in gene therapy, growth factor biology, tissue regeneration and product development. Tissue Repair Company’s clinical targets:

Dermal Wound Repair
(e.g. diabetic ulcers, pressure ulcers, venous stasis ulcers)

Hard Tissue Repair
(e.g. spinal fusion, periodontal tissue repair, bone fractures, cartilage repair)

Tissue Repair Company Recent News

Tissue Repair Company
Media Coverage

of news coverage of MATRIX Excellarate Trial on NEWS 8 in New Haven, CT.

View more videos.
horizontal rule
Cardium Therapeutics
  

Cardium Therapeutics, Inc. is Tissue Repair Company's parent company. Click for website.
 
Home | About TRC | Technology | Product Programs | Preclinical Programs | Investor Information | Contact Us
Site Map | Press Releases | References
Click to read about the Matrix Study Results